Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bioasis Technologies Inc. > Bioasis Connections
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(625)
•••
Comment by KayakerBCon Jun 26, 2022 11:10am
126 Views
Post# 34783018

RE:RE:RE:RE:RE:RE:RE:Bioasis Connections

RE:RE:RE:RE:RE:RE:RE:Bioasis Connections Xb3-001 is my personal pet peeve here,,,,,,,why this platform hasnt been pushed into the clinic is almost ,,,, well maybe criminal,,,,,,JMO......!

"....Many of you will be asking about Bioasis neuro-oncology assets, in particular XB3-001. As indicated at our 2020 shareholders meeting, the board took the strategic decision to pause that program and to divest or out-license XB3-001. This was not because of any lack of faith in the asset. Quite the contrary.  Since that time we have engaged with several potential partners and discussions are ongoing...."

Webinar @ 5:55
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities